Michelle Mello

Michelle Mello Stanford

Michelle Mello, JD, PhD

  • Professor, Health Policy
  • Professor, Law
(650) 725-3894 (voice)

Biography

Michelle Mello is Professor of Law at Stanford Law School and Professor of Health Policy in the Department of Health Policy at Stanford University School of Medicine.  She conducts empirical research into issues at the intersection of law, ethics, and health policy.  She is the author of more than 230 articles on medical liability, public health law, the public health response to COVID-19, pharmaceuticals and vaccines, biomedical research ethics and governance, health information privacy, and other topics.
 
The recipient of a number of awards for her research, Dr. Mello was elected to the National Academy of Medicine at the age of 40.  From 2000 to 2014, she was a professor at the Harvard School of Public Health, where she directed the School’s Program in Law and Public Health.
 
Dr. Mello teaches courses in torts, public health law, and health policy.  She holds a J.D. from the Yale Law School, a Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill, an M.Phil. from Oxford University, where she was a Marshall Scholar, and a B.A. from Stanford University. 

In The News

AI Diagnostic Tool-Illustration
Commentary

How AI Diagnostic Tools Can Lead to Financial Burdens for Patients

According to the co-authors of a perspective published in the New England Journal of Medicine, the use of AI diagnostic tools by medical practitioners can lead to unexpected financial burdens for their patients.
cover link How AI Diagnostic Tools Can Lead to Financial Burdens for Patients
Illustration for Michelle Mello Q&A in The Regulatory Review
Q&As

How Regulations Shape and Constrain Medical Practice

Stanford Health Policy's Michelle Mello discusses how the law, artificial intelligence, and the COVID-19 pandemic have shaped health care in this Q&A with The Regulatory Review.
cover link How Regulations Shape and Constrain Medical Practice
Supreme Court building
Commentary

Ramifications of the Supreme Court’s Latest Term for Health Regulation

The Supreme Court ended its 2024 term with major rulings affecting federal agencies. SHP’s Michelle Mello writes in a JAMA viewpoint that while these rulings have critical ramifications for health agencies, the outlook is more complex than it might appear.
cover link Ramifications of the Supreme Court’s Latest Term for Health Regulation